Avantor (AVG) AI Stock Analysis

Avantor

(XETRA:AVG)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Return to organic growthThe return to organic growth across the company indicates improving demand and execution after a period of weaker performance. Raised full-year guidance and positive fourth-quarter assumptions suggest the recovery may extend beyond one quarter and support more durable revenue momentum.

Negative Factors

Margin pressureIf pricing continues to lag cost inflation, revenue growth may not translate efficiently into earnings or cash flow. Mix effects from faster growth in lower-margin VWR and ongoing investment needs could keep margins below prior peaks and limit profitability recovery.

Avantor (AVG) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 10.88B
Dividend Yield: ―
Average Volume (3M): 206
Price to Earnings (P/E): 32.0
Beta (1Y): 0.20
Revenue Growth: -4.13%
EPS Growth: ―
Country: Germany
Employees: 13,500
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Instruments & Supplies

Avantor Business Overview & Revenue Model

Company Description

Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array...

Avantor Earnings Call Summary

Earnings Call Date:Oct 27, 2026(Q3-2026)|% Change Since:-7.05%|Next Earnings Date:Feb 03, 2027

Earnings Call SentimentPositive

The call was strongly constructive. Avantor reported a return to organic growth, outperformance in both revenue and adjusted EPS, positive performance in VWR and BMP, robust free cash flow, lower leverage, improved order trends, and raised full-year guidance. The main challenges were mix and inflationary margin pressure, foreign-exchange headwinds, BMP comparison effects, pricing that remains below inflation, and a lagging European market. Highlights significantly outweighed the lowlights.

Positive Updates

Return to Organic Revenue Growth

Avantor generated third-quarter revenue of $1.698 billion, representing 5.2% year-over-year organic growth and 4.6% reported growth, exceeding expectations. Management described the quarter as Avantor's return to organic revenue growth and an important milestone in the Revival program.

Negative Updates

Margin Pressure from Mix and Inflation

VWR adjusted operating income was $119 million, with a 9.7% adjusted operating margin. VWR's year-over-year and sequential operating-margin declines primarily reflected mix, inflationary pressures, and growth investments. Company-wide margins also faced pressure because VWR grew faster than BMP and has a lower gross-margin profile.

Company Guidance

For full year 2026, Avantor raised its organic revenue growth outlook to a range of 0.75 to 1.25%, with Q4 organic revenue growth implied at 2.5 to 4.5%; foreign exchange is expected to be a headwind of 150 basis points to reported revenue in Q4 and contribute approximately 75 basis points to full year reported revenue growth. VWR is expected to grow mid single digits in Q4, while BMP is expected to deliver year over year organic growth that is flat to slightly positive, reflecting approximately 400 basis points of headwind from discrete comparisons, with modest sequential growth from Q3 to Q4. Adjusted EBITDA margin guidance remains unchanged and is expected to expand modestly from Q3 to Q4; the adjusted effective tax rate is expected to be between 22% and 22.5%, weighted average diluted share count is expected to be 679 million shares, adjusted EPS guidance is $0.81 to $0.83, and free cash flow guidance is between $520 million and $550 million in 2026, with the adjusted net leverage ratio expected to be below 3x by year end.

Avantor Risk Analysis

Avantor disclosed 39 risk factors in its most recent earnings report. Avantor reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

1 New Risk

1.Our VWR Distribution reporting unit is at risk of goodwill impairment, which could result in a material non-cash charge.Q2, 2026

Avantor Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:AVG against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
WST	78Outperform	$28.74B	46.00	21.08%	0.21%	12.60%	32.05%
RGEN	68Neutral	$11.23B	-842.57	-0.56%	―	13.80%	-811.00%
STVN	68Neutral	$5.29B	36.02	8.94%	0.32%	14.73%	7.43%
AZTA	55Neutral	$1.71B	-14.20	-7.56%	―	1.47%	-9.38%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

* Healthcare Sector Average

Performance Comparison

DE:AVG and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:AVG	Avantor	14.38	3.98	38.27%
AZTA	Azenta, Inc.	39.06	8.33	27.11%
RGEN	Repligen	176.94	26.77	17.83%
WST	West Pharmaceutical Services, Inc.	412.62	133.71	47.94%
STVN	Stevanato Group Spa	19.38	-5.21	-21.19%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Avantor AI Stock Analysis